Gelteq (GELS) Debt Ratio (2023 - 2025)

Gelteq (GELS) recorded quarterly Debt Ratio of 0.2 in Q2 2025, up 36300.79% quarter-over-quarter from 0.0 in Q4 2024, and up 6.06% on a YoY basis from 0.19 in Q2 2024.

Gelteq (GELS) Debt Ratio (2023 - 2025) Analysis & Trends

Gelteq's Debt Ratio history runs 3 years deep, the most recent figure standing at 0.2 for Q2 2025.

  • In Q2 2025, Debt Ratio rose 6.06% year-over-year to 0.2; the TTM figure through Jun 2025 stood at 0.2 (up 6.06% YoY), while the FY2025 annual figure was 0.2, up 6.06% from the prior year.
  • Debt Ratio was 0.2 for Q2 2025 at Gelteq, up from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.2 in Q2 2025 to a low of 0.0 in Q4 2024.
  • Historically, Debt Ratio has averaged 0.12 across 3 years, with a median of 0.15 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Debt Ratio surged 68.17% in 2024, then rose 6.06% in 2025.
  • A 3-year view of Debt Ratio shows it stood at 0.11 in 2023, then plunged by 99.51% to 0.0 in 2024, then surged by 36300.79% to 0.2 in 2025.
  • The last three Debt Ratio figures came in at 0.2 (Q2 2025), 0.0 (Q4 2024), and 0.19 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 0.42
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 0.60
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.01
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.30
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 0.35
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.24
10 Gelteq 10.57 Mn 10.34 Mn - 0.20

Historic Data

Download Data
DateValue
Jun 30, 2025 0.20
Dec 31, 2024 0.00
Jun 30, 2024 0.19
Jun 30, 2023 0.11